These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

70 related articles for article (PubMed ID: 19187353)

  • 1. A conversation between Darracott Vaughan and Marston Linehan.
    Linehan M
    BJU Int; 2009 Feb; 103(3):283-4. PubMed ID: 19187353
    [No Abstract]   [Full Text] [Related]  

  • 2. Searching for the hereditary causes of renal-cell carcinoma.
    Pavlovich CP; Schmidt LS
    Nat Rev Cancer; 2004 May; 4(5):381-93. PubMed ID: 15122209
    [No Abstract]   [Full Text] [Related]  

  • 3. [Brain infarction due to polycythemia as first indication of renal cell carcinoma].
    Niermeijer MF
    Ned Tijdschr Geneeskd; 2006 Jul; 150(29):1642; author reply 1643. PubMed ID: 16903017
    [No Abstract]   [Full Text] [Related]  

  • 4. Prognostic implications of polymorphisms and interleukin-2 therapy for renal cell carcinoma.
    Gardner TA; Logan T
    J Urol; 2009 Aug; 182(2):425-6. PubMed ID: 19524946
    [No Abstract]   [Full Text] [Related]  

  • 5. A cautionary note about the use of different lots of restriction enzymes for DNA fingerprinting.
    Bock S; Epplen JT; Petrides PE
    Genes Chromosomes Cancer; 1995 Jul; 13(3):227. PubMed ID: 7669746
    [No Abstract]   [Full Text] [Related]  

  • 6. Expression and mutational analyses of KIT and PDGFR-alpha in sarcomatoid renal cell carcinoma.
    Petit A; Castillo M; Gaspa A; Colomer D; Garcia de Albéniz X; Moreno C; Camós M; Mellado B; Mallofré C
    Histopathology; 2009 Aug; 55(2):230-2. PubMed ID: 19694830
    [No Abstract]   [Full Text] [Related]  

  • 7. A conversation between Anton Bueschen and Darracott Vaughan. Interviewed by Darracott Vaughan.
    Bueschen A
    BJU Int; 2010 Apr; 105(7):899-900. PubMed ID: 20356322
    [No Abstract]   [Full Text] [Related]  

  • 8. Renal cancer: Genetic directed therapy.
    Loughlin KR
    Urol Oncol; 2009; 27(2):130. PubMed ID: 19285229
    [No Abstract]   [Full Text] [Related]  

  • 9. [Hereditary forms of kidney cancer and genetic screening].
    Valeri A; Cussenot O
    Prog Urol; 2003 Nov; 13(5 Suppl 2):1201-4. PubMed ID: 15816384
    [No Abstract]   [Full Text] [Related]  

  • 10. SDHB--a gene for all tumors?
    Eng C
    J Natl Cancer Inst; 2008 Sep; 100(17):1193-5. PubMed ID: 18728280
    [No Abstract]   [Full Text] [Related]  

  • 11. Wilms tumour as a possible early manifestation of hereditary leiomyomatosis and renal cell cancer?
    Badeloe S; van Spaendonck-Zwarts KY; van Steensel MA; van Marion AM; van Essen AJ; Jonkman MF; Steijlen PM; Poblete-Gutiérrez P; van Geel M; Frank J
    Br J Dermatol; 2009 Mar; 160(3):707-9. PubMed ID: 19183174
    [No Abstract]   [Full Text] [Related]  

  • 12. A conversation between Chris Chapple and Darracott Vaughan. Interview by Darracott Vaughan.
    Chapple C
    BJU Int; 2010 Jun; 105(11):1485-7. PubMed ID: 20553454
    [No Abstract]   [Full Text] [Related]  

  • 13. Birt-Hogg-Dubé syndrome with clear-cell and oncocytic renal tumour and trichoblastoma associated with a novel FLCN mutation.
    Imada K; Dainichi T; Yokomizo A; Tsunoda T; Song YH; Nagasaki A; Sawamura D; Nishie W; Shimizu H; Fukagawa S; Urabe K; Furue M; Hashimoto T; Naito S
    Br J Dermatol; 2009 Jun; 160(6):1350-3. PubMed ID: 19416240
    [No Abstract]   [Full Text] [Related]  

  • 14. Renal cell carcinoma with extensive clear cell change sharing characteristics of mucinous tubular and spindle cell carcinoma and papillary renal cell carcinoma.
    Kuroda N; Tamura M; Hes O; Michal M; Kawada C; Shuin T; Lee GH
    Pathol Int; 2009 Sep; 59(9):687-8. PubMed ID: 19712140
    [No Abstract]   [Full Text] [Related]  

  • 15. Hereditary and familial kidney cancer.
    Coleman JA; Russo P
    Curr Opin Urol; 2009 Sep; 19(5):478-85. PubMed ID: 19584731
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [DNA and microRNA microarray technologies in diagnostics and prediction for patients with renal cell carcinoma].
    Slabý O; Svoboda M; Michálek J; Vyzula R
    Klin Onkol; 2009; 22(5):202-9. PubMed ID: 19886357
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differential expression of KAI1 metastasis suppressor protein in renal cell tumor histological subtypes.
    Kauffman EC; Barocas DA; Chen YT; Yang XJ; Scherr DS; Tu JJ
    J Urol; 2009 May; 181(5):2305-11. PubMed ID: 19303095
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Summary of immunohistologic dissection of the human kidney using monoclonal antibodies (by Neil H. Bander, MD, Carlos Cordon-Cardo, MD, PhD, Connie L. Finstad, PhD, Willet F. Whitmore, Jr, MD, E. Darracott Vaughan, Jr, MD, Herbert F. Oettgen, MD, Myron Melamed, MD, and Lloyd J. Old, MD). 1985.
    Bander NH; Carroll PR; Russo P
    Semin Urol Oncol; 1997 May; 15(2):123-9. PubMed ID: 9134607
    [No Abstract]   [Full Text] [Related]  

  • 19. A Conversation between Darracott Vaughan and John Donohue.
    BJU Int; 2008 Nov; 102(9):1051-2. PubMed ID: 19035906
    [No Abstract]   [Full Text] [Related]  

  • 20. Metastatic renal cell carcinoma: many treatment options, one patient.
    Rini BI
    J Clin Oncol; 2009 Jul; 27(19):3225-34. PubMed ID: 19470934
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.